Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Anna Rita Renzetti"'
Autor:
Sandro Giuliani, Marco Criscuoli, Enzo Perrotta, Carlo Alberto Maggi, Rossano Nannicini, Anna-Rita Renzetti, Nicholas J. S. Harmat, Riccardo Patacchini, Maria Altamura, Danilo Giannotti
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 12:693-696
A series of cyclic pseudopeptides were synthesized containing the sequence -Trp-Phe-( d )-PheΨCH 2 NH-, the terminal ends of which were bound to 2-carboxy succinate or enantiomerically enriched tricarballylic acid to give the final cyclic structures
Autor:
Luigi Rotondaro, Paola Cucchi, Sabrina Zappitelli, Carlo Alberto Maggi, Anna Rita Renzetti, Alessandro Giolitti
Publikováno v:
Neuropharmacology. 39:1422-1429
A series of 14 mutants on nine selected residues of the human tachykinin NK 2 receptor was produced and stably transfected into CHO cells to investigate the binding of the peptide MEN 11420 and the nonpeptide SR 48968 antagonists. The main interactio
Autor:
Anna Rita Renzetti, Silvia Valenza, Franca M. Cordero, Alessandro Giolitti, Maria Altamura, Alberto Brandi, Francesca Giuntini, Antonio Guidi, Franco Pasqui, Carlo Alberto Maggi
Publikováno v:
The Journal of Organic Chemistry. 65:4003-4008
The regioselectivity and the stereoselectivity induced by relatively small peptidomimetic maleic diamide 1 in cycloaddition reactions with cyclic nitrones 2-5 was studied. The high regio- and stereoselectivity observed, sensibly increased by nonpolar
Autor:
Raffaello Giorgi, Stefania Santeusanio, Orazio A. Attanasi, Francesca R. Perrulli, Ada Perrone, Susanna Monti, Anna Rita Renzetti, Lucia De Crescentini, Spartaco Mauro Colombani
Publikováno v:
Il Farmaco. 54:64-76
Based on preliminary molecular modelling study, the synthesis of two different classes of biphenylyltetrazole derivatives of 1-aminopyrroles, as potentially active non-peptide angiotensin II (AII) antagonists, is reported. Some NH -Boc protected 1-am
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 358:395-403
The human tachykinin NK2 receptor stably expressed in Chinese hamster ovary cells (CHO-hNK2R cells) was characterized by studying the effect of neurokinin A (NKA), the preferred natural ligand, and that of other agonists and antagonists in both bindi
Autor:
Anna-Rita Renzetti, A. Lippi, Marco Guelfi, Paola Cucchi, Marco Criscuoli, Carlo Alberto Maggi, R.-M. Catalioto, Laura Quartara
Publikováno v:
Biochemical and Biophysical Research Communications. 248:78-82
[ 3 H]MEN 11420, a radiolabeled glycosylated peptide antagonist of the tachykinin NK 2 receptor, has been investigated in ligand-receptor binding assays using membranes of CHO cells transfected with the human tachykinin NK 2 receptor. [ 3 H]MEN 11420
Autor:
A. Lippi, Marco Criscuoli, Paola Cucchi, Alessandro Lecci, Laura Quartara, C.A. Maggi, Antonio Giachetti, Federico Arcamone, Manuela Tramontana, R.-M. Catalioto, Sandro Giuliani, Riccardo Patacchini, Anna Rita Renzetti, D. Giannotti
Publikováno v:
British Journal of Pharmacology. 123:81-91
1. The pharmacological profile was studied of MEN 11420, or cyclo[[Asn(beta-D-GlcNAc)-Asp-Trp-Phe-Dap-Leu]cyclo(2beta-5beta )], a glycosylated derivative of the potent, selective, conformationally-constrained tachykinin NK2 receptor antagonist MEN 10
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 356:139-144
The tachykinin NK2 receptors present in membranes of rat small intestine were characterized by means of tachykinin receptor agonists and antagonists, by using the natural agonist, NKA, or the nonpeptide antagonist SR 48968, as radioligands. The affin
Autor:
Anna Rita Renzetti, Fabrizio Bonaccorsi, Spartaco Mauro Colombani, C. Ghio, R. Giorgi, Nicholas J. S. Harmat, G. Alagona, Rocco Cirillo, Guido Cerbai, Alessandro Subissi
Publikováno v:
Journal of Medicinal Chemistry. 38:2925-2937
A series of N-[biphenylyl(tetrazolyl)methyl]-2-butylimidazoles containing variously substituted diazine or pyridine moieties either as their free bases or N-oxide derivatives attached to the 4-position of the imidazole ring was synthesized and tested
Publikováno v:
European Journal of Pharmacology: Molecular Pharmacology. 290:151-156
This report describes the molecular pharmacological properties of LR-B/081 (methyl 2-[[4-butyl-2-methyl-6-oxo-5-[ [2′-(1H-tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-1 (6H)-pyrimidinyl]methyl]-3-thiophenecarboxilate), a novel non-peptide angioten